<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedBookArticle><BookDocument><PMID Version="1">30000311</PMID><ArticleIdList><ArticleId IdType="bookaccession">NBK501252</ArticleId></ArticleIdList><Book><Publisher><PublisherName>National Institute of Child Health and Human Development</PublisherName><PublisherLocation>Bethesda (MD)</PublisherLocation></Publisher><BookTitle book="lactmed">Drugs and Lactation Database (LactMed&#xae;)</BookTitle><PubDate><Year>2006</Year></PubDate><BeginningDate><Year>2006</Year></BeginningDate><Medium>Internet</Medium></Book><ArticleTitle book="lactmed" part="LM384">Ranitidine</ArticleTitle><Language>eng</Language><PublicationType UI="D016454">Review</PublicationType><Abstract><AbstractText>Although interpatient variability exists, the dose of ranitidine in breastmilk is less than the dose used in newborn infants. However, the finding that ranitidine spontaneously breaks down to a cancer-causing chemical caused its removal from the market in the US and other countries. Other drugs are recommended.</AbstractText></Abstract><Sections><Section><SectionTitle book="lactmed" part="LM384" sec="LM384.Drug_Levels_and_Effects">Drug Levels and Effects</SectionTitle></Section><Section><SectionTitle book="lactmed" part="LM384" sec="LM384.Substance_Identification">Substance Identification</SectionTitle></Section></Sections><KeywordList Owner="NLM"><Keyword MajorTopicYN="N">ranitidine</Keyword><Keyword MajorTopicYN="N">Gastrosedol</Keyword><Keyword MajorTopicYN="N">Ranitidina</Keyword><Keyword MajorTopicYN="N">Ranitidinum</Keyword><Keyword MajorTopicYN="N">Duractin</Keyword><Keyword MajorTopicYN="N">Gastrial</Keyword><Keyword MajorTopicYN="N">Microtid</Keyword><Keyword MajorTopicYN="N">Ptinolin</Keyword><Keyword MajorTopicYN="N">Ranidine</Keyword><Keyword MajorTopicYN="N">Raniogas</Keyword><Keyword MajorTopicYN="N">Ranitiget</Keyword><Keyword MajorTopicYN="N">Rantacid</Keyword><Keyword MajorTopicYN="N">Raticina</Keyword><Keyword MajorTopicYN="N">Ulceranin</Keyword><Keyword MajorTopicYN="N">Weichilin</Keyword><Keyword MajorTopicYN="N">Xanidine</Keyword><Keyword MajorTopicYN="N">Zantadin</Keyword><Keyword MajorTopicYN="N">Achedos</Keyword><Keyword MajorTopicYN="N">Coralen</Keyword><Keyword MajorTopicYN="N">Istomar</Keyword><Keyword MajorTopicYN="N">Quantor</Keyword><Keyword MajorTopicYN="N">Quicran</Keyword><Keyword MajorTopicYN="N">Radinat</Keyword><Keyword MajorTopicYN="N">Ranisen</Keyword><Keyword MajorTopicYN="N">Raniter</Keyword><Keyword MajorTopicYN="N">Urantac</Keyword><Keyword MajorTopicYN="N">Verlost</Keyword><Keyword MajorTopicYN="N">Vizerul</Keyword><Keyword MajorTopicYN="N">Acidex</Keyword><Keyword MajorTopicYN="N">Atural</Keyword><Keyword MajorTopicYN="N">Axoban</Keyword><Keyword MajorTopicYN="N">Ezopta</Keyword><Keyword MajorTopicYN="N">Logast</Keyword><Keyword MajorTopicYN="N">Mauran</Keyword><Keyword MajorTopicYN="N">Randin</Keyword><Keyword MajorTopicYN="N">Sampep</Keyword><Keyword MajorTopicYN="N">Taural</Keyword><Keyword MajorTopicYN="N">Vesyca</Keyword><Keyword MajorTopicYN="N">Weidos</Keyword><Keyword MajorTopicYN="N">Zantab</Keyword><Keyword MajorTopicYN="N">Curan</Keyword><Keyword MajorTopicYN="N">Ranin</Keyword><Keyword MajorTopicYN="N">Ratic</Keyword><Keyword MajorTopicYN="N">Ul-Pep</Keyword><Keyword MajorTopicYN="N">UNII-884KT10YB7</Keyword><Keyword MajorTopicYN="N">884KT10YB7</Keyword><Keyword MajorTopicYN="N">HSDB 3925</Keyword><Keyword MajorTopicYN="N">EINECS 266-332-5</Keyword><Keyword MajorTopicYN="N">66357-35-5</Keyword><Keyword MajorTopicYN="N">EC 266-332-5</Keyword><Keyword MajorTopicYN="N">N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine</Keyword><Keyword MajorTopicYN="N">1,1-Ethenediamine, N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-</Keyword></KeywordList><ContributionDate><Year>2024</Year><Month>9</Month><Day>15</Day></ContributionDate><ReferenceList><Reference><Citation>Riley AJ, Crowley P, Harrison C. Transfer of ranitidine to biological fluids: Milk and semen. In: Misiewicz J, Wormsley K, eds. The clinical use of ranitidine. Oxford: Medicine Publishing Foundation; 1982:78-81.</Citation></Reference><Reference><Citation>Kearns GL, McConnell RF, Jr, Trang JM, et al. Appearance of ranitidine in breast milk following multiple dosing. Clin Pharm 1985;4:322-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">4039999</ArticleId></ArticleIdList></Reference><Reference><Citation>Knigge UP. Histaminergic regulation of prolactin secretion. Dan Med Bull 1990;37:109-24.</Citation><ArticleIdList><ArticleId IdType="pubmed">2188799</ArticleId></ArticleIdList></Reference><Reference><Citation>Perret G, Hugues JN, Louchahi M, et al. Effect of a short-term oral administration of cimetidine and ranitidine on the basal and thyrotropin-releasing hormone-stimulated serum concentrations of prolactin, thyrotropin and thyroid hormones in healthy volunteers. A double-blind cross-over study. Pharmacology 1986;32:101-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">3081918</ArticleId></ArticleIdList></Reference><Reference><Citation>Delitala G, Devilla L, Pende A, et al. Effects of the H2 receptor antagonist ranitidine on anterior pituitary hormone secretion in man. Eur J Clin Pharmacol 1982;22:207-11.</Citation><ArticleIdList><ArticleId IdType="pubmed">6125393</ArticleId></ArticleIdList></Reference><Reference><Citation>Knigge U, Wollesen F, Dejgarrd A, et al. Comparison between dose-responses of prolactin, thyroid stimulating hormone and growth hormone to two different histamine H-2 receptor antagonists in normal men. Clin Endocrinol (Oxf) 1981;15:585-92.</Citation><ArticleIdList><ArticleId IdType="pubmed">6276054</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosi S, Cagnoli M. Painful gynecomastia with ranitidine. Lancet 1982;2:160.</Citation><ArticleIdList><ArticleId IdType="pubmed">6123872</ArticleId></ArticleIdList></Reference><Reference><Citation>Bera F, Jonville-Bera AP, Doustin P, et al. Impotence and gynecomastia secondary to hyperprolactinemia induced by ranitidine. Therapie 1994;49:361-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">7878608</ArticleId></ArticleIdList></Reference></ReferenceList></BookDocument><PubmedBookData><History><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30000311</ArticleId></ArticleIdList></PubmedBookData></PubmedBookArticle></PubmedArticleSet>